
|Articles|November 15, 2002
Second Course
Efalizumab retreatment works as effectively as original treatmentPhysician: Kim A. Papp, M.D.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Clinicians See Intersection of Weight Loss and Facial Aging
2
The “6-7” Advances for Dermatologists to Look Forward to in 2026
3
Soquelitinib Phase 1 Data Show Sustained Clinical Improvement With Extended Treatment in AD
4
Q&A: Saami Khalifian, MD, FAAD, on Integrating BOTOX Cosmetic into Lower Face and Neck Rejuvenation
5


















